PolyPeptide Group AG
SIX:PPGN

Watchlist Manager
PolyPeptide Group AG Logo
PolyPeptide Group AG
SIX:PPGN
Watchlist
Price: 16.7 CHF 7.19% Market Closed
Market Cap: 553.3m CHF

Intrinsic Value

The intrinsic value of one PPGN stock under the Base Case scenario is 29.2 CHF. Compared to the current market price of 16.7 CHF, PolyPeptide Group AG is Undervalued by 43%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PPGN Intrinsic Value
29.2 CHF
Undervaluation 43%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
PolyPeptide Group AG

PPGN
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for PPGN cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

PolyPeptide Group AG
SIX:PPGN
CH
Life Sciences Tools & Services
Market Cap
551m CHF
IPO
Apr 29, 2021
CH
Life Sciences Tools & Services
Market Cap
551m CHF
IPO
Apr 29, 2021
Price
CHffalse
EPS
€false
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PPGN?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about PolyPeptide Group AG
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
PolyPeptide Group AG

Balance Sheet Decomposition
PolyPeptide Group AG

Current Assets 328.2m
Cash & Short-Term Investments 68.3m
Receivables 94.3m
Other Current Assets 165.7m
Non-Current Assets 428.4m
Long-Term Investments 5.2m
PP&E 389m
Intangibles 15m
Other Non-Current Assets 19.2m
Efficiency

Free Cash Flow Analysis
PolyPeptide Group AG

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
PolyPeptide Group AG

Revenue
338.8m EUR
Cost of Revenue
-299.3m EUR
Gross Profit
39.5m EUR
Operating Expenses
-45.3m EUR
Operating Income
-5.9m EUR
Other Expenses
-13.7m EUR
Net Income
-19.6m EUR
Fundamental Scores

PPGN Profitability Score
Profitability Due Diligence

PolyPeptide Group AG's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
Positive Gross Profit
Positive 1-Year Revenue Growth
34/100
Profitability
Score

PolyPeptide Group AG's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

PPGN Solvency Score
Solvency Due Diligence

PolyPeptide Group AG's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Negative Net Debt
48/100
Solvency
Score

PolyPeptide Group AG's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PPGN Price Targets Summary
PolyPeptide Group AG

Wall Street analysts forecast PPGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PPGN is 30.6 CHF with a low forecast of 19.19 CHF and a high forecast of 47.25 CHF.

Lowest
Price Target
19.19 CHF
15% Upside
Average
Price Target
30.6 CHF
83% Upside
Highest
Price Target
47.25 CHF
183% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PPGN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

PPGN Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one PPGN stock?

The intrinsic value of one PPGN stock under the Base Case scenario is 29.2 CHF.

Is PPGN stock undervalued or overvalued?

Compared to the current market price of 16.7 CHF, PolyPeptide Group AG is Undervalued by 43%.

Back to Top